论文部分内容阅读
AIM To investigate the prognostic role of invariantnatural killer T (iNKT) cells and antibody-dependentcell-mediated cytotoxicity (ADCC) in wild type KRASmetastatic colorectal cancer (mCRC) patients treated withcetuximab.METHODS: Forty-one KRAS wt mCRC pa